Lexeo Therapeutics Inc. C... (LXEO)
NASDAQ: LXEO
· Real-Time Price · USD
3.95
0.01 (0.25%)
At close: Jun 16, 2025, 3:59 PM
3.97
0.51%
Pre-market: Jun 17, 2025, 08:30 AM EDT
0.25% (1D)
| Bid | 3.8 |
| Market Cap | 131.13M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -109.31M |
| EPS (ttm) | -3.31 |
| PE Ratio (ttm) | -1.19 |
| Forward PE | -1.95 |
| Analyst | Buy |
| Ask | 4.24 |
| Volume | 512,535 |
| Avg. Volume (20D) | 1,019,387 |
| Open | 4.06 |
| Previous Close | 3.94 |
| Day's Range | 3.83 - 4.24 |
| 52-Week Range | 1.45 - 19.50 |
| Beta | 0.52 |
About LXEO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LXEO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LXEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+50.92%
Lexeo Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
7 months ago
-0.65%
Lexeo Therapeutics shares are trading higher. Leerink Partners maintained an Outperform rating on the stock.
1 month ago · seekingalpha.com
Lexeo: Alignment Gained With FDA Brings Further LX2006 Program AdvancementLexeo Therapeutics, Inc. established further positive interim data from phase 1/2 SUNRISE-FA study using LX2006 for the treatment of patients with Friedreich's Ataxia Cardiomyopathy. Pivotal LXEO regi...
